Previous studies showed that RBMS3 was mainly found in nuclei and its low expression in nuclei predicted unfavorable prognosis for patients with LSCC, NPC and ESCC [9, 10, 12]. This evidence concerns the gene RBMS3 and esophageal squamous cell carcinoma.